Dr. Stephan Fleck joined Rottendorf in 2009 as Chief Executive Officer of Rottendorf Pharma GmbH in Germany. Since June 1st, 2018 he serves Rottendorf Pharma GmbH as Executive Officer for Technology / Business / Strategy, while he continues holding the position of CEO for Rottendorf Pharma, Inc. in the USA.
Stephan Fleck has extensive knowledge of the pharmaceutical industry and technical operations, having worked within this field of expertise for more than three decades. He began his career at Bayer AG in 1980, moving to the US, joining Bayer Diagnostics in 1998, where he held various leading positions. After 7 years, Stephan Fleck moved back to Germany to take up leading positions in strategic planning, technical operations and product supply areas with Bayer HealthCare. Stephan Fleck has furthermore held the position of Vice President of Technical Operations at a GE Healthcare Life Science division in London and was earlier a member of the DELPHI Group at CERN in Switzerland.
Stephan Fleck holds a degree in Industrial Technology from the University of Aachen (Germany), a degree in Physics from the University of Wuppertal (Germany) and a PhD in Engineering from the University of Magdeburg (Germany).